KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Common Equity (2016 - 2025)

Nu Skin Enterprises (NUS) has disclosed Common Equity for 17 consecutive years, with $805.2 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 23.61% to $805.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $805.2 million through Dec 2025, up 23.61% year-over-year, with the annual reading at $805.2 million for FY2025, 23.61% up from the prior year.
  • Common Equity hit $805.2 million in Q4 2025 for Nu Skin Enterprises, up from $799.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $941.0 million in Q2 2022 to a low of $651.5 million in Q4 2024.
  • Historically, Common Equity has averaged $834.3 million across 5 years, with a median of $832.1 million in 2022.
  • Biggest five-year swings in Common Equity: fell 23.36% in 2024 and later increased 23.61% in 2025.
  • Year by year, Common Equity stood at $912.8 million in 2021, then fell by 1.7% to $897.3 million in 2022, then fell by 8.4% to $822.0 million in 2023, then decreased by 20.74% to $651.5 million in 2024, then rose by 23.61% to $805.2 million in 2025.
  • Business Quant data shows Common Equity for NUS at $805.2 million in Q4 2025, $799.8 million in Q3 2025, and $787.8 million in Q2 2025.